Brett A. Giffin
CIK: 0001892921
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
T2 Biosystems, Inc.
Discretionary Trading P&L
Holdings
Brett A. Giffin files insider reports with the SEC as Chief Commercial Officer of T2 Biosystems, Inc. (TTOO). Signal8 holds 2 reported Form 4/5 transactions by Brett A. Giffin since Sep 2024. The most recent reported transaction is a grant / award (Form 4 code A) in TTOO, dated Nov 4, 2024.
About Giffin Brett A.
Giffin Brett A. (SEC CIK 0001892921) files insider reports with the SEC as Chief Commercial Officer of T2 Biosystems, Inc. (TTOO).
Signal8 holds 1 ownership filing by Giffin Brett A., a Form 4, filed on Jan 2, 2025. Those filings report 2 transactions, the latest on Nov 4, 2024. Signal8's Form 4 history starts in Sep 2024.
The business address on Giffin Brett A.'s filings is in LEXINGTON, MA.
Recent filings by Giffin Brett A.
- Nov 4, 2024: Grants or awards of TTOO derivative securities (2 lines, Form 4, code A).
Other insiders filing for T2 Biosystems, Inc. (TTOO)
- LIEBMAN SEYMOUR, Director
- Adams Laura Lee, Director
- CUMMING JOHN W, Director
- Gibbs Michael Terrence, General Counsel
- Saunders Ninfa, Director
- Toft Robin, Director